Key History
Key Physical Exam
Risk Factors for PE
Differential Diagnosis
Diagnostic Testing
Wells Criteria & PERC Rule
Clinical Risk and Safety Pearls
Treatment
Pregnancy
Pulmonary Embolism (PE), the Great Imposter, should be considered in virtually any
ED visit related to weakness, shortness of breath, dizziness or syncope, pain, extremity
discomfort, or nonspecific malaise or functional deterioration.
- Classic triad (presents less than 20% of the time):
- Dyspnea
- Chest pain (pleuritic)
- Hemoptysis
- Syncope
- Cough (37%) or common URI symptoms (PIOPED study)
- Dyspnea (73%)
- Pleuritic chest pain (66%)
- Hemoptysis (13%)
- Syncope
- Fever
- Wheezing
|
- Abdominal pain
- New onset of atrial fibrillation
- Decreasing level of consciousness
- Pleuritic chest pain without other symptoms or risk factors
- Leg swelling and pain
- History of DVT
- Recent long trip
- Immobilization
- Greenfield filter placement
- History of PE
|
Back To Top
Most common in PIOPED study
|
- Tachypnea – 70%
- Rales – 51%
- Tachycardia – 30%
- Fourth heart sound - 24%
|
- Accentuated pulmonic component of second heart sound – 23%
- Hypoxemia
- Pleural Rub
- New right-sided heart failure
- Tachycardia
|
Back To Top
- Active cancer
- Atrial fibrillation
- Cancer (may be undiagnosed)
- Cardiomyopathy
- Congestive heart failure
- Coagulation disorder
- Factor V Leiden disorder
- Greenfield filter placement
- History of venous thromboembolus (VTE) (DVT or PE)
- Hormone replacement therapy, oral contraceptives, estrogen use
|
- Immobility in the past 4 weeks (leg cast, bedrest, hospitalization)
- Myocardial infarction
- Obesity
- Pregnancy/Postpartum
- Protein C or S deficiency
- Recent trauma, burn or surgery
- Smoking
- Stroke
- Surgery in past 60–90 days
- General anesthesia
- Travel: long plane or car rides
|
Back To Top
- Anxiety disorder
- Aortic stenosis
- Cholecystitis
- Cholelithiasis
- Congestive heart failure
- Coronary artery disease
- Costochondritis
- Esophageal rupture
- Esophagitis
- Gastritis
- GERD
- Herpes zoster
- Hiatal hernia
|
|
|
Back To Top
Text / literature information and recommendations include:
- Lab:
- CBC: WBC count can be normal or elevated.
- D-dimer — D-dimer is a degradation product of cross-linked fibrin.
- MUST use ELISA test and not the latex agglutination tests (SimpliRed
®, etc) due
to low overall sensitivity: 50-60%
- ELISA tests are much more sensitive – but still miss up to 10% of
patients with
a PE. Overall, the negative predictive value of an ELISA D-dimer
indicates that
patients with a normal D-dimer have a 95 percent likelihood of not
having PE.
- The use of ELISA D-dimer assays for the diagnosis of PE have been
extensively studied,
and the test is noted to have a good sensitivity and negative
predictive value,
but a poor specificity. The best, validated strategy is to first
quantify the patient’s
pretest probability of having a PE. Patients with low pre-test
probability (using
a validated pretest instrument such as the Wells’ criteria) AND a
negative quantitative
D-dimer (ELISA or turbidimetric) have a 98-99% probability of not
having a PE and
the work-up can be safely stopped. The D-dimer is NOT sensitive
enough to rule out
PE in patients with intermediate or high-risk pretest probability,
and these patients
require further study.
- Need further imaging if
- The D-dimer is positive
- The pretest probability for PE is intermediate or high Wells' criteria for PE
- D-dimer is not as reliable in patients with active malignancy or
recent surgery.
- ECG
- Usually normal and nonspecific
- Most common ECG abnormality is sinus tachycardia
- May show anterior/lateral T wave inversions
- ST elevation in AVR
- S1Q3T3 pattern – rare and nonspecific
- Imaging
CXR:
- Usually normal, but may show atelectasis, infiltrates or a pleural effusion
- Hampton's hump: opacity with rounded border pointing towards hilum (area of
infarction)
- Westermark's sign: increased lucency from clot interrupting blood flow
- Fleischner's sign: large, sausage-shaped pulmonary artery
V/Q scan
- Used when CTA not available or patient has contraindication to CT or IV
contrast
- Should be used in conjunction with a validated pretest probability
stratification
scheme
- Normal V/Q scan in 4% of patients will still have PE (PIOPED Study)
- High-probability scan effectively rules in PE (87% with this pattern have
PE)
- Non-diagnostic scan - indication for definitive test, usually angiography
High Resolution Spiral (Helical) CT Angiography (CTA)
- Can typically resolve down to 3rd order vessels
- Less invasive; no PA catheters
- Sensitivity: 56-100%
- May miss subsegmental artery PE
- IV contrast; can provide alternate diagnosis
- Can be used as an alternative to V/Q scan (ACEP level B)
- Thin columnation spiral CT of thorax (1-2 mm)
- Eventual role as screening modality or criterion standard test still
controversial
Pulmonary Angiogram
- Still the gold standard for diagnosis
- Negative angiogram essentially excludes PE (> 90%).
- Positive angiogram is definitive proof of PE
- Can be useful even if the study is abbreviated
- Indications:
- Other studies non-diagnostic
- High risk of bleeding with treatment
- Mortality: up to 0.3% (elderly, pulmonary HTN)
- Complications: 2-4%
- Some patients may exhibit hypersensitivity to dye
- Arrhythmias, cardiac perforation
Ultrasound/Echocardiography
- Good for suspected massive PE performed at bedside, otherwise of limited
accuracy
- A positive US proves PE
- Echocardiography can visualize clots, and show right ventricular strain
- Transtracheal echocardiography is up to 85% sensitive in massive PE,
Transesophageal
sensitivity up to 90% with 100% specificity
MRI
- MRI has a sensitivity of 85% and specificity of 96% for central, lobar, and
segmental
emboli.
- MRI is inadequate for the diagnosis of subsegmental emboli.
Back To Top
Back To Top
- The literature now supports a risk stratification strategy as described above.
- Immediate full anticoagulation for patients suspected to have DVT and/or PE is
suggested.
- Diagnostic testing should not delay empirical anticoagulant therapy.
- D-dimer is not helpful if the patient has an active malignancy or recent surgery.
- Up to 60% of patients with a PE have a normal Doppler study of lower extremity.
- The onset of SOB typically occurs a few days before the patient presents to the
ED with complaints.
- Less than half of patients present with sudden onset of SOB or chest pain.
Back To Top
Common text / literature recommendations include:
- For PE without associated cancer diagnosis, direct oral anticoagulants (DOACs) are
recommended over warfarin therapy.
- For patients with PE and no cancer who are not treated with DOACs, warfarin is
recommended over LMWH.
- Initial parenteral anticoagulation is given before dabigatran and edoxaban; is not
given before rivaroxaban and apixaban; and is overlapped with warfarin therapy.
- For patients with PE and cancer, either LMWH or DOACs are recommended.
- For patients with acute PE and hypotension (massive PE), thrombolytic therapy may be
appropriate.
- Inferior vena cava filter is not recommended for patients with PE who are treated
with anticoagulants.
Back To Top
Risk increased during pregnancy and the postpartum period
Pulmonary embolism is the leading cause of death in pregnancy.
- If the patient has a low pretest probability for pulmonary embolism and a normal
D-dimer test result, clinical exclusion from further investigations is recommended.
- If the clinical features are compatible with PE, CT scanning is performed; previous
recommendations for VQ have been replaced by current studies, which suggest CT is
safer in pregnancy.
- IF VQ scan is performed:
- If the perfusion scan is normal, the diagnosis of PE is excluded.
- If a segmental defect in perfusion with normal ventilation (high-probability
lung
scan) is seen, the diagnosis of PE is confirmed.
- Patients with non-diagnostic lung scans should undergo CUS; if this is
abnormal,
PE can be diagnosed.
- If CUS is normal, D-dimer, pulmonary angiography, or serial CUS should be
considered,
provided that the limitations of these tests are understood.
Treatment: LMWH is the preferred drug for the treatment of PE during pregnancy.
Back To Top
|